1. A Phase 1 Trial of TPI 287 as a Single Agent and in Combination With Temozolomide in Patients with Refractory or Recurrent Neuroblastoma or Medulloblastoma. Issue 1 (31st July 2015) Authors: Mitchell, Deanna; Bergendahl, Genevieve; Ferguson, William; Roberts, William; Higgins, Timothy; Ashikaga, Takamaru; DeSarno, Mike; Kaplan, Joel; Kraveka, Jacqueline; Eslin, Don; Werff, Alyssa Vander; Hanna, Gina K.; Sholler, Giselle L. Saulnier Journal: Pediatric blood & cancer Issue: Volume 63:Issue 1(2016) Page Start: 39 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Feasibility of implementing molecular‐guided therapy for the treatment of patients with relapsed or refractory neuroblastoma. (26th February 2015) Authors: Saulnier Sholler, Giselle L.; Bond, Jeffrey P.; Bergendahl, Genevieve; Dutta, Akshita; Dragon, Julie; Neville, Kathleen; Ferguson, William; Roberts, William; Eslin, Don; Kraveka, Jacqueline; Kaplan, Joel; Mitchell, Deanna; Parikh, Nehal; Merchant, Melinda; Ashikaga, Takamaru; Hanna, Gina; Lescaul... Journal: Cancer medicine Issue: Volume 4:Number 6(2015:Jun.) Page Start: 871 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗